Nykode Therapeutics AS Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	63.93	115.4	162.6	206.39	216.23	183.85
Trading Asset Securities	-	-	-	-	12.17	24.94
Cash & Short-Term Investments	63.93	115.4	162.6	206.39	228.4	208.8
Cash Growth	-48.70%	-29.03%	-21.21%	-9.64%	9.39%	555.64%
Accounts Receivable	-	-	-	2.54	23.75	18.75
Other Receivables	3	0.91	1.07	1.79	2.41	1.34
Receivables	3	0.91	1.07	4.33	26.16	20.09
Prepaid Expenses	-	0.76	2.01	1.15	1.3	0.15
Other Current Assets	-	-	-	-	-	-0
Total Current Assets	66.93	117.07	165.68	211.87	255.86	229.03
Property, Plant & Equipment	6.19	7.74	10.52	9.53	9.17	0.41
Other Intangible Assets	0.07	0.07	0.07	0.03	0.03	0.03
Long-Term Deferred Charges	-	-	-	-	0.48	0.55
Other Long-Term Assets	32.51	28.6	31.92	0.05	0.02	0.01
Total Assets	105.7	153.48	208.19	221.48	265.56	230.03
Accounts Payable	1.99	0.86	1.33	2.31	2.75	1.61
Accrued Expenses	-	3.62	6.08	7.58	9.3	9.68
Current Portion of Leases	1.28	1.29	1.46	1.15	1.35	0.28
Current Income Taxes Payable	0.02	0.02	-	0.08	0.03	-
Current Unearned Revenue	-	-	8.34	19.87	16.26	-
Other Current Liabilities	0.62	3.3	3.41	8	1.69	1.61
Total Current Liabilities	3.91	9.1	20.61	38.99	31.37	13.18
Long-Term Leases	1.62	2.15	4.27	4.37	5.82	0.01
Long-Term Deferred Tax Liabilities	-0.02	5.2	12.05	21.08	29.4	31.13
Other Long-Term Liabilities	0.94	0.82	0	0.03	4.91	6.86
Total Liabilities	6.45	17.27	36.93	64.46	71.5	51.18
Common Stock	0.37	0.37	0.37	0.34	0.33	0.33
Additional Paid-In Capital	96.71	128.99	128.99	83.32	81.53	60.35
Retained Earnings	-13.19	-8.76	29.56	64.71	107.46	116.87
Comprehensive Income & Other	15.37	15.62	12.35	8.65	4.74	1.31
Shareholders' Equity	99.25	136.21	171.26	157.02	194.06	178.85
Total Liabilities & Equity	105.7	153.48	208.19	221.48	265.56	230.03
Total Debt	2.9	3.44	5.73	5.51	7.17	0.28
Net Cash (Debt)	61.03	111.96	156.88	200.87	221.23	208.51
Net Cash Growth	-49.17%	-28.63%	-21.90%	-9.20%	6.10%	556.60%
Net Cash Per Share	0.20	0.34	0.52	0.69	0.77	0.70
Filing Date Shares Outstanding	326.55	326.55	326.55	294.69	289.62	284.79
Total Common Shares Outstanding	326.55	326.55	326.55	294.69	289.62	284.79
Working Capital	63.03	107.97	145.07	172.89	224.49	215.85
Book Value Per Share	0.30	0.42	0.52	0.53	0.67	0.63
Tangible Book Value	99.18	136.14	171.19	156.99	194.02	178.82
Tangible Book Value Per Share	0.30	0.42	0.52	0.53	0.67	0.63
Machinery	-	5.02	4.97	3.44	1.46	0.2

Source: S&P Global Market Intelligence. Standard template. Financial Sources.